Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Neurofascin as a novel target for autoantibody-mediated axonal injury
2007
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
2007
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Virus-Induced Autoimmunity: Potential Role of Viruses in Initiation, Perpetuation, and Progression of T-Cell–Mediated Autoimmune Disease
2001
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
2014
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study
1999
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.
1998
Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis
2004
Interleukin-17 Family Members and Inflammation
2004 Standout
Rheumatoid arthritis
2016 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
2009 StandoutNobel
Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
1999
Autopsy report of acute necrotizing opticomyelopathy associated with thyroid cancer
1993
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Regulation of Adaptive Immunity; The Role of Interleukin-10
2013
B cells and antibodies in CNS demyelinating disease
2001
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis
2003
Modulation of Glycan Recognition by Clustered Saccharide Patches
2014
Active induction of experimental allergic encephalomyelitis
2006
Structure and physical map of 64 variable segments in the 3′ 0.8–megabase region of the human immunoglobulin heavy–chain locus
1993 StandoutNobel
Myelin basic protein‐dependent plasma membrane reorganization in the formation of myelin
2006 StandoutNobel
Guillain-Barré syndrome
2016 Standout
Multiple sclerosis: a unique immunopathological syndrome of the central nervous system
1995
Guillain–Barré Syndrome
2012 Standout
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
2014 Standout
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
2009
Tolerance and Autoimmunity
2001
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
2009
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
2008
Multiple sclerosis
2008 Standout
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
2006
Pathogenesis of multiple sclerosis
1994
Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair
2010
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
2017
The pathology of primary progressive multiple sclerosis
2004
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Structural Imaging in Parkinson’s Disease: New Developments
2019
Accumulation of immunoglobulin across the ‘blood–nerve barrier’ in spinal roots in adoptive transfer experimental autoimmune neuritis
2002
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
2002
The origin and application of experimental autoimmune encephalomyelitis
2007
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis
2002
Identification of autoantibodies associated with myelin damage in multiple sclerosis
1999
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis
1997
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Antigen-specific therapeutic approaches for autoimmunity
2019
Susceptibility to multiple sclerosis is associated with the proximal immunoglobulin heavy chain variable region.
1991
The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders
2014
The immunology of stroke: from mechanisms to translation
2011 Standout
Increased expression and function of glutamate transporters in multiple sclerosis
2005
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function
2008 Standout
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial
2009
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
X-linked adrenoleukodystrophy enigma: How does the ALD peroxisomal transporter mutation affect CNS glia?
2000
Minireview: Autoimmune responses to myelin proteolipid protein
1994
Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions
2003
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice
2009
Multiple Sclerosis
2000 Standout
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
2007
Immune Tolerance to Myelin Proteins
2003
Functional Genomic Analysis of Oligodendrocyte Differentiation
2006
Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein
1997
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis
1992 Standout
Myelin basic protein—diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis
2004
A possible harmful late effect of methylprednisolone therapy on a time cluster of optic neuritis
1989
Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System
1996
Guillain-Barré syndrome
2005 Standout
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
2015
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
2008
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Recognition and Degradation of Myelin Basic Protein Peptides by Serum Autoantibodies: Novel Biomarker for Multiple Sclerosis
2008
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The Epitopes Targeted by the Rheumatoid Arthritis-Associated Antifilaggrin Autoantibodies are Posttranslationally Generated on Various Sites of (Pro)Filaggrin by Deimination of Arginine Residues
1999
Multiple Sclerosis
2018 Standout
IL-17 and Th17 Cells
2009 Standout
Identification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
2002
Increased T Cell Autoreactivity in the Absence of CD40-CD40 Ligand Interactions: A Role of CD40 in Regulatory T Cell Development
2001 StandoutNobel
The role of B cells and autoantibodies in multiple sclerosis
2000
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
NF-κB-Inducing Kinase Establishes Self-Tolerance in a Thymic Stroma-Dependent Manner
2004 StandoutNobel
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
A humoral response to oligodendrocyte-specific protein in MS
1999
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
2009
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions
2016
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
1996 Science
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
1996
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+T cells
2000 StandoutNobel
Autoantibodies frequently detected in patients with aplastic anemia
2003
Tolerogenic Dendritic Cells
2003 StandoutNobel
CD8+ T Cells Are a Biologically Relevant Source of Macrophage Inflammatory Protein-1α In Vivo
1999 StandoutNobel
High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.
1992
Physiology of Microglia
2011 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
1996 StandoutScience
Works of Ingrid Catz being referenced
An Extensive Search for Autoantibodies to Myelin Basic Protein in Cerebrospinal Fluid of Non-Multiple-Sclerosis Patients: Implications for the Pathogenesis of Multiple Sclerosis
1999
Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter
2014
Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
1997
Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosis
1994
Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis
1993
Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid
1992
Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue
1993
Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid
1994
Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85VVHFFKNIVTP96 in chronic progressive multiple sclerosis
1997
A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients
1990
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatment
2006
Lipid microarrays identify key mediators of autoimmune brain inflammation
2005
Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients
1989
A correlation between cerebrospinal fluid mylein basic protein and anti–myelin basic protein in multiple sclerosis patients
1987
Intrathecal Synthesis of Autoantibodies to Myelin Basic Protein in Multiple Sclerosis
1986
Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein
2005
Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features.
1995
Effect of Methylprednisolone on CSF IgG Parameters, Myelin Basic Protein and Anti-Myelin Basic Protein in Multiple Sclerosis Exacerbations
1986
Diagnostic value of cerebrospinal fluid anti–myelin basic protein in patients with multiple sclerosis
1986
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron
2013